Studies related to LDL-C and Ganoderma lucidum

Ganoderma Lucidum ("Lingzhi"), A Chinese Medicinal Mushroom: Biomarker Responses In A Controlled Human Supplementation Study

Effect None
Trial Design Double blind
Trial Length 2-4 Weeks
Number of Subjects 18
Sex n/a
Age Range 18-29, 30-44
Body Types Average
Notes for this study:
A toxicology study noted no significant influences on blood lipoprotein markers or TGs, just a non-significant beneficial trend in otherwise healthy adults. No influence was noted on superoxide dismutase, glutathione peroxidase, DNA damage as assessed by comet assay, C-RP, or total antioxidant defenses. No influence on the CD4:CD8 lymphocytic ratio was noted, and total leucocytes were unchanged.

The dosing was 1.44g extract (13.2g mushroom equivalent) for 29 days in otherwise healthy adults.